IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Pharmaceutical patent analyst

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

0.83

h-Index

2022-2023

 19

Rank

2022-2023

 17570

SJR

2022-2023

 0.233

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Pharmaceutical patent analyst
Abbreviation Pharm. pat. anal.
Publication Type Journal
Subject Area, Categories, Scope Pharmaceutical Science (Q3); Drug Discovery (Q4); Medicine (miscellaneous) (Q4)
h-index 19
Overall Rank/Ranking 17570
SCImago Journal Rank (SJR) 0.233
Impact Score 0.83
Publisher Newlands Press Ltd
Country United Kingdom
ISSN 20468954, 20468962
Best Quartile Q3
Coverage History 2012-2018, 2021-2022




About Pharmaceutical patent analyst


Pharmaceutical patent analyst is a journal covering the technologies/fields/categories related to Pharmaceutical Science (Q3); Drug Discovery (Q4); Medicine (miscellaneous) (Q4). It is published by Newlands Press Ltd. The overall rank of Pharmaceutical patent analyst is 17570. According to SCImago Journal Rank (SJR), this journal is ranked 0.233. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 19. The best quartile for this journal is Q3.

The ISSN of Pharmaceutical patent analyst journal is 20468954, 20468962. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Pharmaceutical patent analyst is cited by a total of 46 articles during the last 3 years (Preceding 2022).


Pharmaceutical patent analyst Impact IF 2022-2023


The Impact IF 2022 of Pharmaceutical patent analyst is 0.83, which is computed in 2023 as per its definition. Pharmaceutical patent analyst IF is increased by a factor of 0.05 and approximate percentage change is 6.41% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Pharmaceutical patent analyst Impact IF 2023 Prediction


Impact IF 2022 of Pharmaceutical patent analyst is 0.83. If the same upward trend persists, Impact IF may rise in 2023 as well.


Impact IF Trend


Year wise Impact IF of Pharmaceutical patent analyst. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 0.83
2021 0.78
2020 1.15
2019 0.90
2018 0.60
2017 0.78
2016 0.82
2015 0.68
2014 0.59

Pharmaceutical patent analyst h-index


  Table Setting

Pharmaceutical patent analyst has an h-index of 19. It means 19 articles of this journal have more than 19 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Pharmaceutical patent analyst ISSN


The ISSN of Pharmaceutical patent analyst is 20468954, 20468962. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Pharmaceutical patent analyst Rank and SCImago Journal Rank (SJR)


The overall rank of Pharmaceutical patent analyst is 17570. According to SCImago Journal Rank (SJR), this journal is ranked 0.233. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Pharmaceutical patent analyst by Year


Year SJR
2023/2024 Coming Soon
2022 0.233
2021 0.331
2020 0.247
2019 0.247
2018 0.307
2017 0.358
2016 0.414
2015 0.370
2014 0.368

Ranking of Pharmaceutical patent analyst by Year


Year Ranking
2023/2024 Coming Soon
2022 17570
2021 13866
2020 16853
2019 16299
2018 13541
2017 11821
2016 10747
2015 11561
2014 11299

Pharmaceutical patent analyst Publisher


Table Setting

Pharmaceutical patent analyst is published by Newlands Press Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2012-2018, 2021-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Pharmaceutical patent analyst is Pharm. pat. anal.. This abbreviation ('Pharm. pat. anal.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Pharmaceutical patent analyst


If your research field is/are related to Pharmaceutical Science (Q3); Drug Discovery (Q4); Medicine (miscellaneous) (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Pharmaceutical patent analyst?

Pharmaceutical patent analyst latest impact IF is 0.83. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 1.15 (2020) and 0.59 (2014), respectively, in the last 9 years. Moreover, its average IS is 0.79 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Pharmaceutical patent analyst?

The Pharmaceutical patent analyst has an SJR (SCImago Journal Rank) of 0.233, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.414 in 2016 and the lowest being 0.233 in 2022. Furthermore, the average SJR of the Pharmaceutical patent analyst over the previous 9-year period stands at 0.79.


What's the latest h-index of the Pharmaceutical patent analyst?

The latest h-index of the Pharmaceutical patent analyst is 19.


Who's the publisher of the Pharmaceutical patent analyst?

The Pharmaceutical patent analyst is published by the Newlands Press Ltd, with its country of publication being the United Kingdom.


What's the current ranking of the Pharmaceutical patent analyst?

The Pharmaceutical patent analyst is currently ranked 17570 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 10747 in 2016 and its lowest position of 17570 in 2022.


What's the abbreviation or short name for the Pharmaceutical patent analyst?

The standard ISO4 abbreviation for the Pharmaceutical patent analyst is Pharm. pat. anal..


Is the "Pharmaceutical patent analyst" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Pharmaceutical patent analyst is classified as a journal that the Newlands Press Ltd publishes.


What's the scope or major areas of the Pharmaceutical patent analyst?

The Pharmaceutical patent analyst encompasses the following areas:

  • Pharmaceutical Science
  • Drug Discovery
  • Medicine (miscellaneous)

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Pharmaceutical patent analyst?

The Pharmaceutical patent analyst is assigned the following International Standard Serial Numbers (ISSN): 20468954, 20468962.


What's the best quartile of the Pharmaceutical patent analyst?

The best quartile for the Pharmaceutical patent analyst is Q3 (2022).


What's the coverage history of the Pharmaceutical patent analyst?

The Pharmaceutical patent analyst coverage history can be summarized as follows: 2012-2018, 2021-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Sex Education journal 5168 Routledge 41 2.82
Palaeontographica Abteilung B: Palaeophytologie book series 15138 E. Schweizerbart'sche Verlagsbuchhandlung 16 2.20
European Journal of Wildlife Research journal 8709 Springer Verlag 56 1.99
HOMO- Journal of Comparative Human Biology journal 19810 Elsevier BV 35 0.56
WSEAS Transactions on Environment and Development journal 17731 World Scientific and Engineering Academy and Society 23 1.33
PLoS ONE journal 5108 Public Library of Science 404 3.75
Innovations in Pharmaceutical Technology trade journal 26994 Samedan Ltd 9 0.00
Asian Journal of Animal and Veterinary Advances (discontinued) journal 15083 Academic Journals Inc. 28 3.00
Acta Bioethica journal 23565 Universidad de Chile - Centro Interdisciplinario de Estudios en Bioetica 10 0.38
Epites-Epiteszettudomany journal 23580 Akademiai Kiado 4 0.06

Check complete list




Year wise Impact Score (IS) of Pharmaceutical patent analyst

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 0.83
2021 0.78
2020 1.15
2019 0.90
2018 0.60
2017 0.78
2016 0.82
2015 0.68
2014 0.59



Top Journals/Conferences in Pharmaceutical Science

Nano Today
Elsevier | Netherlands

Advanced Drug Delivery Reviews
Elsevier | Netherlands

Advanced healthcare materials
John Wiley and Sons Ltd | United Kingdom

Journal of Controlled Release
Elsevier | Netherlands

Bioengineering and Translational Medicine
John Wiley & Sons Inc. | United States

Apoptosis : an international journal on programmed cell death
Springer Netherlands | Netherlands

Journal of Nanobiotechnology
BioMed Central Ltd. | United Kingdom

Asian Journal of Pharmaceutical Sciences
Shenyang Pharmaceutical University | China

Journal of Pharmaceutical Analysis
Xi'an Jiaotong University | China

Bioconjugate Chemistry
American Chemical Society | United States

See All

Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Protein and Cell
Higher Education Press | China

Emerging Microbes and Infections
Taylor and Francis Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Molecular Therapy - Nucleic Acids
Cell Press | United States

Journal of Medicinal Chemistry
American Chemical Society | United States

Antibodies
MDPI AG | Switzerland

See All

Top Journals/Conferences in Medicine (miscellaneous)

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Physiological Reviews
American Physiological Society | United States

MMWR supplements
Epidemiology Program Office | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

See All